{
    "code": "51059784",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51059784",
    "time": "2019-12-27 03:08:23",
    "許可證字號": "衛部藥製字第059784號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/10\/03",
    "發證日期": "106\/10\/03",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105978400",
    "中文品名": "&quot;永信&quot;健法凍晶注射劑",
    "英文品名": "Gemphar Lyo-Injection &quot;Yung Shin&quot;",
    "適應症": "非小細胞肺癌、胰臟癌、膀胱癌。GEMCITABINE與PACLITAXEL併用，可使用於曾經使用過ANTHRACYCLINE之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑類藥物(PLATINUM-BASED)治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。膽道癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "200毫克、1公克玻璃小瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 24監視期滿學名藥",
        "申請商名稱": "0502110200  永信藥品工業股份有限公司",
        "申請商地址": "台中市大甲區頂店里中山路一段1191號",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(eq. to Gemcitabine.....200mg)",
            "含量": "228.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(eq. to Gemcitabine.....1gm)",
            "含量": "1140.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "1.6.3 GLI藥品外觀-106-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059784&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "510597840001-108-11-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059784&Seq=002&Type=9"
        },
        {
            "title": "510597840001-106-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059784&Seq=001&Type=9"
        },
        {
            "title": "510597840006-106-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059784&Seq=005&Type=8"
        },
        {
            "title": "510597840005-106-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059784&Seq=004&Type=8"
        },
        {
            "title": "510597840004-106-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059784&Seq=003&Type=8"
        },
        {
            "title": "510597840003-106-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059784&Seq=002&Type=8"
        },
        {
            "title": "510597840002-106-12-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51059784&Seq=001&Type=8"
        }
    ]
}